Enterprise Value
-23.8M
Cash
104.5M
Avg Qtr Burn
-18.69M
Short % of Float
4.46%
Insider Ownership
0.49%
Institutional Own.
60.68%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PBFT02 (AAV1) Details Neurological disorder, Frontotemporal dementia | Phase 1/2 Data readout | |
PBGM01 (AAVhu68 viral vector) Details Rare genetic disease, Neurological disorder | Failed Discontinued |